CHAPTER 21
MALIGNANT MELANOMA, MELANOCYTIC NEVI
AND THEIR SIMULATORSiˆ««•FŽîAF‘f«•ê”Á‚Æ—ÞŽ—Çj
I. Origin of Melanoma Cells and Biological Characteristics
A. Origin of Melanoma Cellsi•FŽî×–E‚Ì‹NŒ¹j
1. Melanoma cells derive from malignant transformation of melanocytes.
2. Melanocytes originate embryologically from neural crest tissues.
3. Melanocytes are dendritic and are located in the basal layer of the epidermis.
4. Melanocytes possess a unique biological property, i.e., synthesis of melanin and melanosomes, which is responsible for unique brown black coloration of malignant melanoma.
B. Biological Characteristicsi¶•¨Šw“I“Á«j
Melanoma cells are derived from 2 ways:
(1) de novo malignant transformation of normal epidermal melanocytesi³í•\”烃‰ƒmƒTƒCƒg‚̋NJˆ««•ω»j, and
(2) malignant transformation of pre-existing nevus cells, i.e., nevo-melanocytic cellsiŠù‘¶‚Ì•ê”Á×–E‚ÌŠà‰»j.
These two cell types are located above the basement membrane of the epidermis of the skin and mucosa. It is generally accepted that 50% of melanoma occurs from de novo malignant transformation of normal epidermal melanocytes and the remaining 50% derives from malignant transformation of pre-existing nevus cells.
II. Growth Pattern, Clinical Subtypes and Histopathological Correlation
A. Growth Pattern
Two major growth patterns of melanoma cells:
1. Radial, lateral along epidermal surface
2. Vertical, invasive to dermis
B. Growth Pattern and Clinical Subtypes of Melanoma
Based upon these unique growth patterns of malignant
melanocytes, there are 4 major subtypes of malignant
melanoma. These are:
1. Lentigo maligna melanomaiˆ««•ŽqŒ^ˆ««•FŽîj- LMM
2. Superficial spreading melanomai•\Ý«Šg‘嫈««•FŽîj - SSM
3. Nodular melanomaiŒ‹ß«ˆ««•FŽîj- NM
4. Acral lentiginous melanomai––’[•ŽqŒ^ˆ««•FŽîj- ALM
LMN, SSM and ALM have both radical and vertical growth phases, whereas, nodular melanoma takes only vertical growth phase. Each subtype has unique clinical and histopathological features as well as distribution in the body which will be discussed in the following.
C. Lentigo Maligna Melanomaiˆ««•ŽqŒ^ˆ««•FŽîj
1. Least common form of melanoma in Caucasians; most common in Orientals
2. Almost exclusively limited to the markedly sun-exposed skin of face and neck, cheek being the most common
3. Long period of radial growth phase, 3-15 years
4. Flat lesion with various shades of tan, brown, black and occasional hypopigmentation (regression)
5. 3-6 cm in size: average age of onset being 65 years
6. Extensive variation in morphologic features of epidermal melanocytes in tan, brown and flat black lesions
D. Superficial Spreading Melanomai•\Ý«Šg‘嫈««•FŽîj
1. Most commonly diagnosed in 4th and 5th decades (average 44)
2. Most frequent histopathological and clinical variant of melanoma among Caucasians (70%)
3. Palpable lesion with various shades of brown, black, grey and red; definite angular notches or protrusions.
4. 2.5 cm in size, 1-7 years of radial growth phase
5. Most frequently involving trunk, back in men and lower legs in women
6. Most frequently associated with contiguous melanocytic nevi
E. Nodular MelanomaiŒ‹ß«ˆ««•FŽîj
1. Next most prevalent subtype after SSM in Caucasians
2. Most common site: trunk in men and legs in women
3. Rapid evolution, 6 to 18 months on average
4. 1 to 2 cm in size: dark, blueberry-like nodule or raised plaque with quite uniform dark discoloration
5. Affecting all sites
6. Median age 53 years
7. Little tendency for intraepidermal growth
8. Invasion of dermis conjointly with any area of intraepidermal invasion
F. Acral Lentiginous Melanomai––’[•ŽqŒ^ˆ««•FŽîj
1. Relatively infrequent among Caucasians (2-8%), but most common in dark-skinned people
2. Involves acral parts of body, sole being most common
3. Older individuals: 65 years
4. Similar clinical and histopathological appearance to SSM but much more aggressive
1. Macular, lateral growth component with irregular borders and variegation in coloration
2. Basilar proliferation of large melanocytes with elongated dendrites
All these 3 types of melanoma occurs on the trunk, face and limbs affecting primarily the sun?exposed areas. There is a remarkable difference for the distribution of melanoma on the lower legs between men and women, with the women showing a higher incidence of melanoma on the calves where the sunlight may reflect, through the asphalt because women wear skirts. In contrast, the melanoma incidence for men on lower legs are low because the sites are usually covered by pants.
H. Comparative Histologic Features of the Radial Growth Phases of Acral Lentiginous, Superficial Spreading, and Lentigo Maligna Types
|
ACRAL LENTIGINOUS MELANOMA |
LENTIGO MALIGNA MELANOMA |
SUPERFICIAL SPREADING MELANOMA |
Location of melanoma cells within the epidermis |
Basilar region |
Basilar region |
All epidermal layers |
Cytology of the individually disposed intraepidermal melanocytes |
Uniformly large with prominent, complex dendrites |
Pleomorphic - "normal" and bizarre melanocytes mixed. Dendrites inconspicuous |
Uniformly large epithelioid cells without prominent dendrites |
Histology of the intraepidermal nests of melanocytes |
Nests tend to bulge into dermis |
Nests may be ellipsoidal in outline with the long axis tending to parallel the epidermal surface |
Nests quite large frequently bridging the entire thickness of the epidermis |
Cytology of the melanocytes forming the intraepidermal nests |
Cells tend to be spindle shaped, may be epithelioid |
Cells are pleomorphic, some quite small, others large and bizarre |
Uniformly large epithelioid cells form the nests |
Invasion of the papillary dermis |
Present, but may require search to find it |
Essentially absent |
Easily demonstrated |
Solar changes in connective tissue |
Absent |
Present |
Variable |
Host response of lymphocytes and macrophages |
Present and prominent with extension into epidermis |
Minimal to absent |
Usually well developed |
Clark WC Jr et al, in Human Malignant Melanoma, Grane & Stratton
III. Unusual Forms of Melanoma
A. Subungual Melanomai’Üb‰º•FŽîj
B. Amelanotic Melanomai–³F‘f«•FŽîj
C. Mucosal Melanomasi”S–Œ•FŽîj: mouth, eye, ear, nose, anorectum, vagina
D. Eye Melanoma (uveal or ciliochoroidal)
E. Leptomeningeal Melanomai“î”]–Œ•FŽîj
F. Unknown Primary Melanoma
IV. Prognostic Factors for Cutaneous Melanoma
A. Clinical Variables
1. Age - worse prognosis with increasing age
2. Sex - women have better prognosis than men
3. Anatomic site - extremity more favorable prognosis
B. Histologic Variables of Primary Tumor
1. Tumor thickness - worse prognosis with increasing thickness
2. Levels of invasion - worse prognosis with deeper levels
3. Ulceration - worse prognosis with presence of ulceration
4. Regression - increased risk for metastasis in tumors < 1.0 mm with marked regression
The tumor invasion is divided into 5 levels and the tumor thickness is measured from the top of the granular layer to the bottom of the tumor. The tumor thickness as well as the level of invasion have a fairly good correspondence to the overall 5-year survival. If the tumor has a Level V invasion and tumor thickness of more than 3.0 mm, the patient will unfortunately die with a risk of more than 50% no matter what treatment is used on the patient.
In contrast, if the tumor is located with the papillary dermis, having < 0.75 mm in tumor thickness, you may be able to get a 5-year survival rate, i.e., more than 98-99% cure. If the tumor is confined to the epidermis, a 100% cure rate is obtained.
One should also be careful for the high risk thin melanoma which has a tumor thickness < 1.0 mm but has a regression. The regression of the primary melanoma does not mean a good prognosis but it shows a poorer prognosis. One has to be very careful to tell the patient requiring the prognosis even though the primary tumor shows less than 1.0 mm in tumor thickness. In our practice, we usually see at least 10% of melanoma metastasis from these thin melanoma group.
C. Anatomic Distribution of Mucosal Malignant Melanomas
Location |
No. |
% of all Melanomas |
Skin |
899 |
85.6 |
Eyes |
102 |
9.7 |
Central Nervous System |
2 |
0.2 |
Mucosal Primary Lesions |
47 |
4.5 |
TOTAL | 1,050 | 100.1 |
CCABC = Cancer Control Agency of British Columbia
D. Anatomic Distribution of Mucosal Malignant Melanomas
Location
|
No.
|
% of all Melanomas
|
Head & Neck |
20 |
1.9 |
Vulva |
14 |
1.3 |
Vagina |
7 |
0.7 |
Anal Canal |
3 |
0.2 |
Female Urethra |
2 |
0.1 |
Esophagus |
1 |
0.1 |
TOTAL
|
47
|
4.5
|
CCABC = Cancer Control Agency of British Columbia
E. Risk Factors for the Development of Malignant Melanoma
1. Pigmentary Characteristics
a. Blue eyes
b. Blond, fair, or red hair
c. Fair or pale complexion
2. Response to Sun Exposure
a. Tendency to sunburn
b. Inability to tan (skin prototype I)
c. Freckling tendency
3. Upper socioeconomic status
F. 5-Year Survival of Cutaneous Melanoma
Level of Invasion |
Clark, et al |
McGovern et al |
Wanebo et al |
Balch et al |
Eldh et al |
I |
--- |
--- |
--- |
--- |
--- |
II |
72(36) |
82(51) |
100(29) |
85(36) |
100(67) |
III |
47(71) |
65(62) |
88(58) |
72(70) |
87(111) |
IV |
32(76) |
49(53) |
65(58) |
57(78) |
72(127) |
V |
12(25) |
29(17) |
16(6) |
28(28) |
35(19) |
G. Risk Factors for the Development of Malignant Melanoma
1. Family history of melanoma
2. Sex, reproductive, and hormonal status
3. Melanocytic nevi
a. Increased numbers of nevi
b. Atypical nevus characteristics
1) Increased nevus size
2) Irregular border
3) Variegated color
c. Nevi with architectural and cytological atypia (dysplastic nevi)
d. Congenital nevi
4. History of nonmelanoma skin cancer
V. Treatment of Melanoma
A. Principle
1. Primary cutaneous melanoma; surgical excision with/without skin graft
2. Regional metastasis; complete lymph node dissection. Hyperthermic regional limb perfusion
3. Distant metastasis:
a. surgery: skin, lung, brain and GI metastasis
b. radiation therapy: brain metastasis, pain of bone
c. chemotherapy: dacarbazine (DTIC) with/without combination of VCR, ACNU, BLM, and/or cisplatin
d. immunotherapy: IFN, TNF, IL-2, TILs with IL-2
e. gene therapy: ?
B. Margins of Surgical Resection for Clinical Stage I Melanoma
Tumor Thickness, mm |
Margins of Surgical Resection, cm |
in situ |
0.5 |
< 1.0 |
1 |
1.0 - 1.5 |
1.5 |
1.5 - 4.0 |
2 to 3 |
> 4.0 |
3 |
VI. Differential Diagnosis and Precursors of Melanoma
A. Possible Precursors of Human Melanoma and Differential Diagnosis
1. Common acquired nevomelanocytic nevusi’ÊíŒ^Œã“V«F‘f×–E«•ê”Áj
2. Acquired dysplastic melanocytic nevusiŒã“V«ˆÙŒ^F‘f×–E«•ê”Áj
3. Congenital nevomelanocytic nevusiæ“V«F‘f×–E«•ê”Áj
4. Halo nevomelanocytic nevusi”’ò•ê”Áj
5. Spitz's nevusiƒXƒsƒbƒc•ê”Ájor juvenile melanomaiŽá”N«•FŽîj
6. Blue nevusiÂF•ê”Áj
7. Dermal melanocytosisi^”烃‰ƒmƒTƒCƒg[ƒVƒXj
8. Lentigo simplexi’Pƒ•Žqj, lentigo senilesi˜Vl«F‘f”Áj (solar lentigo)
9. Lentigo maligna iˆ««•Žqj
B. Common Acquired Nevomelanocytic Nevus
1. Appears after the first 6 to 12 months of life, enlarges with body growth and regresses in later life.
2. Darker skin is associated with fewer nevi (2-8 in American blacks vs 14-15 whites).
3. Prevalence of pigmented line on nail beds in race-related; 20-23% in Japanese, 96% in blacks older than 50 yrs and extremely rare in Whites.
4. Prevalence of nevi on conjunctivae and acral parts is race-related; 0.9% in whites and 4% in blacks.
5. Pigmented lesions on external genitalia are common in all races, 10-14%
C. Acquired Dysplastic Melanocytic NevusiŒã“V«ˆÙŒ^F‘f×–E«•ê”Áj
1. Dysplasia derives from Greek, dys ("bad") and plasis (molding), referring abnormal tissue development.
2. Fairly unique clinical features: flat surface relative to breadth, irregular and/or fuzzy outlines, irregular coloration, and "fried-egg" appearance.
3. Unique histopathological features: basilar proliferation of atypical nevomelanocytes, lentiginous or epithelioid-cell patterns of intraepidermal melanocytic proliferation, concentric eosinophilic fibrosis, neovascularization and dermal inflammatory response.
D. Familial Dysplastic Nevus Syndromei‰Æ‘°«ˆÙŒ^•ê”ÁÇŒóŒQj
1. Laboratory evidence of increased sensitivity to UVR
2. Increased propensity to develop dysplastic nevi in sun-exposed areas
3. Autosomal dominant
4. High risk for melanoma development from moles: 80-100% and 56% by age 76 and 20?59 years, respectively
5. Not all family members have an equal risk of melanoma development; the more moles the higher the risk for melanoma
E. Comparison of Common Nevus and Dysplastic Nevus
1. Common Nevusi’ÊíŒ^•ê”Áj
a. any site, sparing of "sun-protected" area
b. smooth, regular, well-demarcated outline
c. majority < 5 mm
d. orderly, symmetric distribution of no more than 2 colors
e. round or oval
f. dome shaped
2. Dysplastic nevusiˆÙŒ^•ê”Áj
a. any site, but common in "horse collar" area
b. irregular, poorly demarcated outline
c. usually > 5 mm
d. disorderly, haphazard display of more than 2 colors
e. fried egg shaped
F. Congenital Nevomelanocytic Nevus
1. Apparent at birth, showing a number of variants; garment nevus, bathing trunk nevus, hairy nevus, giant nevus, verrucous nevus, divided nevus
2. Lifetime risk of melanoma development is high for giant nevus, at least 6.3%, and grave with sudden appearance of dermal or subcutaneous nodule.
3. Giant nevi of head/neck or posterior midline are associated with underlying cranial or spinal leptomeningeal melanocytosis; neurocutaneous melanosis having a poor prognosis (obstructive hydrocephalus)
G. Spitz's NevusiƒXƒsƒbƒc•ê”Áj
1. Called also as juvenile melanoma because of histopathologically bizarre appearance
2. Benign acquired nevomelanocytic nevus
3. Solitary, asymptomatic, pink or red, hairless, firm dome-shaped telangiectatic papular nodule
4. Compound nevus with bizarre mononuclear and multinuclear giant cells, nuclear polymorphism but no atypical mitosis, cleft formation of junctional nest, widely dilated blood vessels
H. Blue NevusiÂF•ê”Áj
1. Acquired or congenital blue, blue-grey, or blue-black papule, nodule, or plaque-like aggregate of aberrant dermal melanocytes actively producing melanin
2. Common blue nevus: benign and no malignancy
3. Cellular blue nevus: larger, more elevated and more aggressive locally than the common form and a variety of melanoma may develop
4. Ectopic accumulation of melanin-producing melanocytes in dermis during their migration from neural crest to site in skin
I. Lentigoi•Žqj
1. Derive from Latin lens, "lentil", small brown spots
2. Lentigo simplex: melanocytic hyperplasia
3. Solar lentigo: brown spots caused by natural or artificial UVR and increased number of dendritic melanocytes without nesting
4. Lentigo maligna: intraepidermal in situ melanoma or melanocytic dysplasia
VII. Simulators of Malignant Melanoma
A. Melanotic Lesions
1. Simple lentiginesi’Pƒ•Žqj, and junctional and compound types of melanocytic nevi with features of simple lentigines
2. Solar lentiginesi“úŒõ•Žqj
3. Seborrheic keratosesiމ˜R«Šp‰»Çj
4. Dermatofibromasi”畆üˆÛŽîj
5. Pigmented basal-cell carcinomasiF‘f«Šî’ê×–EŠàj
B. Hemorrhagic Extravasations
Hemorrhage in the cornified layer of the epidermis, nail bed, or nail plate
1. HemangiomasiŒŒŠÇŽîj
2. Thrombosed capillary aneurysmsiŒŒð«–Ñ׌ŒŠÇ«“®–¬áŽj
3. Kaposi's sarcomaiƒJƒ|ƒW“÷Žîj
D. Adventitious Pigmentations, Particularly from Carbon
Tattoos - commercial and traumatic
E. Pigmentation Produced by Micro-Organisms
Tinea nigrai•áj
F. Pyogenic Granulomai‰»”^«“÷‰èŽîj
ƒˆ««•FŽîгŽÒ‚Ì5”N¶‘¶—¦„
Stage |
TNM |
thickness |
level |
5”N¶‘¶—¦ |
I |
pT1 |
<0.75 or 0.75 mm |
II |
100% |
|
pT2 |
0.75<<1.5 or 1.5 mm |
III |
|
II |
pT3a |
1.5<<3.0 or 3.0 mm |
IV |
75% |
|
pT3b |
3.0<<4.0 or4.0 mm |
IV |
|
III |
pT4a |
4.0 mm< |
V |
50% |
|
pT4b |
satellite (s) |
2 cmˆÈ“à‚̔畆A”牺“]ˆÚ |
|
|
N1 |
’·Œa3 cmˆÈ‰º‚ÌŠ‘®ƒŠƒ“ƒpß“]ˆÚ |
|
|
|
N2a |
’·Œa3 cm‚ð‰z‚¦‚銑®ƒŠƒ“ƒpß“]ˆÚ |
|
|
|
N2b |
in-transit |
2 cm‚ð‰z‚¦‚é”畆A”牺“]ˆÚ |
|
|
N2c |
N2a and N2b |
|
|
IV |
M1a |
(Š‘®ƒŠƒ“ƒpß‚ð‰z‚¦‚½”畆A”牺AƒŠƒ“ƒpß“]ˆÚ) |
2”N¶‘¶—¦ |
|
|
M1b |
(ŒŒs«“]ˆÚ) |
|
20%ˆÈ‰º |
ƒ•ê”ÁiƒzƒNƒj‚ƃƒ‰ƒm[ƒ}‚Ì—Õ°“IŠÓ•Ê„
A: asymmetry: ”ñ‘ÎÆ«
B: Border irregular: •Ó‰•s‹K‘¥
C: Color variegated:F’²‚ª‘½Ê
D: Diameter: ’¼Œa
E: Elevation (Enlargement): —²‹Ni‘‘åj